Quarterly report pursuant to Section 13 or 15(d)

NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

v2.4.0.8
NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2013
Nature Of Business And Summary Of Significant Accounting Policies Tables  
Schedule Fair Value Options

The fair value of each stock option grant on the date of grant is estimated using the Black-Scholes option-pricing utilizing the following weighted average assumptions:

 

  NINE MONTHS ENDED SEPTEMBER 30,
       2013           2012     

Risk-free interest rates

Expected option life in years

Expected stock price volatility

Expected dividend yield

0.78% -1.24%

 5 years

43.54% - 44.31%

-0-

0.71%-0.89%

5 years

45.86%

- 0 -

Schedule Earnings Per Share

Computations of basic and diluted weighted average common shares outstanding are as follows:

 

 

 

Nine Months Ended

September 30,

Three Months Ended

September 30,

  2013 2012 2013 2012
         
Weighted-average common shares outstanding – basic 25,387,348 25,659,085 25,792,387  25,963,093
Dilutive effect of options and warrants 2,075,010  2,885,887 2,397,196  2,553,549

Weighted-average common shares outstanding – diluted

 

27,462,358  28,544,972 28,189,583  28,516,642
Options and Warrants excluded from the computation of diluted income (loss) per share because the effect of inclusion would have been anti-dilutive 5,132,490 2,574,113 4,810,304 2,906,451
Schedule of Cash and Cash Equivalents

Cash and cash equivalents as of September 30, 2013 and December 31, 2012 are composed of: 

 

  September 30, 2013 December 31, 2012
     
Cash $  1,823,000       $   1,346,000        
Money market fund 17,761,000  20,637,000 
Total $   19,584,000      

$ 21,983,000        

 

 

Schedule of Investment

At September 30, 2013, the Company’s investment in Lifestream consists of the following:

 

Number of

   Shares   


   Value   
Common Stock 250,000 $       76,000
Series A Preferred Stock 123,456          50,000
Warrants 1,305,000            70,000
    $     196,000